CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 151 enrolled
Drug / intervention
behavioral counseling plus contingency managementbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00861146
NCT00861146Phase 2Completed
CompareCT.gov

Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk

Yale University·interventional·Posted Mar 13, 2009·Updated Apr 3, 2020

In Brief

A Phase 2 clinical trial evaluating behavioral counseling plus contingency management for Tobacco Use Cessation and Alcohol-related Disorders. Completed, enrolled 151 participants across 2 sites.

Detailed Summary

The majority of individuals with alcohol problems remain current smokers, and the negative health consequences of smoking among these individuals are substantial. This study will investigate the impact of smoking cessation interventions initiated during intensive alcohol treatment on processes reflecting risk of alcohol relapse.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Cessation, Alcohol-related Disorders
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 13, 2009
Enrollment StartApr 1, 2009
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.3 years ago

Interventions

behavioral counseling plus contingency managementbehavioral

Individual counseling sessions with voucher rewards for smoking abstinence, transdermal nicotine patch and nicotine gum